Skip to main content

Table 3 Results based on reference glucose and insulin-infusion data

From: Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial

 

Local protocol (n= 12)

Automated closed-loop (n= 12)

P

Primary end point

   

Time glucose in target (%) (6.0-8.0 mM)

18.5 (0.1-39.9)

54.3 (44.1-72.8)

0.001

Secondary end points

   

Starting glucose (mM)

10.8 (9.9-12.0)

10.0 (8.9-11.1)

0.21

Mean glucose (mM)

9.1 (8.3-13.0)

7.9 (7.4-8.2)

0.001

Standard deviation of glucose (mM)

1.9 (0.8)

1.3 (0.5)

0.089

Time spent at glucose levels (%)

  4.0-10.0 mM

73.2 (21.2-89.4)

93.3 (86.5-100.0)

0.002

  5.6-10.0 mM

73.2 (21.2-82.4)

92.2 (83.4-99.2)

0.001

  >8.0 mM

78.4 (57.6-99.9)

39.0 (23.5-51.4)

0.001

  >10.0 mM

26.8 (10.5-78.8)

6.7 (0-13.5)

0.002

  <6.0 mM

0 (0-3.0)

4.6 (3.1-8.3)

0.028

  <5.6 mM

0 (0-0)

0.7 (0-2.7)

0.128

  <4.0 mM

0 (0-0)

0 (0-0)

NA

Hypoglycemia

   

  Episodes <4.0 mM

None

None

 

  Hypoglycemia treatments

None

None

 

Hyperglycemia

   

  Number of subjects ≥15 mM

5 (42%)

1 (8%)

 

  Number of subjects ≥17 mM

4 (33%)

1 (8%)

 

  Episodes ≥15 mM

11

1

 

  Episodes ≥17 mM

13

1

 

Insulin-infusion data

   

  Total units for 24 hours

40.9 (34.9-101.4)

57.4 (40.0-112.2)

0.478

   Hourly infusion rate

1.7 (1.5-4.2)

2.4 (1.7-4.7)

0.478

Total dextrose infusion for 48 hours (g)

0.21 (0.0-5.2)

NA

NA

  1. Data shown are mean (SD) or median (interquartile range).